1. Armata I, Prakash A. An update on the assessment and management of hirsutism. Obstet Gynecol Reprod Med 2024; 34: 81-7.
2.
Elliott J, Liu K, Motan T. Guideline No. 444: hirsutism: evaluation and treatment. J Obstet Gynaecol Can 2023; 45: 102272.
3.
Vaidya T, Hohman MH, Kumar D. Laser Hair Removal. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 25, 2023.
4.
Bhat YJ, Bashir S, Nabi N, et al. Laser treatment in hirsutism: an update. Dermatol Pract Concept 2020; 10: e2020048.
5.
López-Alarcón M, Vital-Reyes VS, Almeida-Gutiérrez E, et al. Obesity and hyperandrogenemia in polycystic ovary syndrome: clinical implications. J Pers Med 2023; 13: 1319.
6.
Sahin Y, Kelestimur F. Medical treatment regimens of hirsutism. Reprod Biomed Online 2004; 8: 538-46.
7.
Hafsi W, Kaur J. Hirsutism. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 3, 2023.
8.
Forslund M, Melin J, Alesi S, et al. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Endocrinol 2023; 189: S1-16.
9.
Shah D, Patil M. National PCOS Working Group. Consensus statement on the use of oral contraceptive pills in polycystic ovarian syndrome women in India. J Hum Reprod Sci 2018; 11: 96-118.
10.
Mihailidis J, Dermesropian R, Taxel P, et al. Endocrine evaluation of hirsutism. Int J Womens Dermatol 2017; 3: S6-10.
11.
Forslund M, Melin J, Alesi S, et al. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review. Clin Endocrinol 2023; 99: 79-91.
12.
Wooltorton E. Diane-35 (cyproterone acetate): safety concerns. CMAJ 2003; 168: 455-6.
13.
Alesi S, Forslund M, Melin J, et al. Correction of meta-analysis after retraction of article on the effects of anti-androgens in polycystic ovary syndrome. EClinicalMedicine 2024; 79: 103009.
14.
Tahvilian R, Ebrahimi A, Beiki O, et al. Preparation and clinical evaluation of Finastride gel in the treatment of idiopathic Hirsutism. J Drug Assess 2015; 4: 12-8.
15.
Soares Júnior JM, Guimarães DZ, Simões RDS, et al. Systematic review of finasteride effect in women with hirsutism. Rev Assoc Med Bras (1992) 2021; 67: 1043-9.
16.
Oliveira-Soares R, André MC, Peres-Correia M. Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women. Int J Trichol 2018; 10: 48-50.
17.
Fraison E, Kostova E, Moran LJ, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev 2020; 8: CD005552.
18.
Barrionuevo P, Nabhan M, Altayar O, et al. Treatment options for hirsutism: a systematic review and network meta-analysis. J Clin Endocrinol Metab 2018; 103: 1258-64.
19.
Sachdeva S. Hirsutism: evaluation and treatment. Indian J Dermatol 2010; 55: 3-7.
20.
Agrawal NK. Management of hirsutism. Indian J Endocrinol Metab 2013; 17: S77-82.
21.
Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018; 103: 1233-57.
22.
Castelo-Branco C, Cancelo MJ. Comprehensive clinical management of hirsutism. Gynecol Endocrinol 2010; 26: 484-93.
23.
Vaidya T, Hohman MH, Kumar DD. Laser Hair Removal. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 25, 2023.
24.
van Zuuren EJ, Fedorowicz Z, Carter B, et al. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Datab Syst Rev 2015; 4: CD010334.
25.
Bazarganipour F, Ziaei S, Montazeri A, et al Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome. Iran J Reprod Med 2013; 11: 829-36.
26.
Harrington AG, Overall NC. Women’s attractiveness contingent self-esteem, romantic rejection, and body dissatisfaction. Body Image 2021; 39: 77-89.
27.
Chishti SH, Rafiq M. Psychosocial issues, coping strategies and psychological symptoms of hirsute women. Pak J Med Res 2019; 58: 141-8.
28.
Matheson E, Bain J. Hirsutism in women. Am Fam Physician 2019; 100: 168-75.
29.
Agrawal NK. Management of hirsutism. Indian J Endocrinol Metab 2013; 17: S77-82.
30.
Spritzer PM, Marchesan LB, Santos BR, et al. Normal androgens and diagnosis of PCOS. Diagnostics 2022; 12: 1922.
31.
Dong J, Rees DA. Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Med 2023; 2: e000548.
32.
S³opieñ R, Milewska E, Rynio P, et al. Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age. Prz Menopauzalny 2018; 17: 1-4.
33.
Markovski M, Hall J, Jin M, et al. Approach to the management of idiopathic hirsutism. Can Fam Physician 2012; 58: 173-7.
34.
Mihailidis J, Dermesropian R, Taxel P, et al. Endocrine evaluation of hirsutism. Int J Womens Dermatol 2017; 3: S6-10.
35.
Cumming DC, Yang JC, Rebar RW, et al. Treatment of hirsutism with spironolactone. JAMA 1982; 247: 1295-8.
36.
Sachdeva S. Hirsutism: evaluation and treatment. Indian J Dermatol 2010; 55: 3-7.
37.
Soares Júnior JM, Guimarães DZ, Simões RDS, et al. Systematic review of finasteride effect in women with hirsutism. Rev Assoc Med Bras 2021; 67: 1043-9.
38.
Hunter MH, Carek PJ. Evaluation and treatment of women with hirsutism. Am Fam Physician 2003; 67: 2565-72.
39.
Luque-Ramírez M, Nattero-Chávez L, Ortiz Flores AE, et al. Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2018; 24: 225-41.
40.
Ezeh U, Huang A, Landay M, et al. Long-term response of hirsutism and other hyperandrogenic symptoms to combination therapy in polycystic ovary syndrome. J Womens Health 2018; 27: 892-902.
41.
Eisenhardt S, Schwarzmann N, Henschel V, et al. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2006; 91: 946-52.
42.
Rivkees SA. Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the “growth toxic” glucocorticoid. Int J Pediatr Endocrinol 2010; 2010: 569680.
43.
Rababa’h AM, Matani BR, Yehya A. An update of polycystic ovary syndrome: causes and therapeutics options. Heliyon 2022; 8: e11010.
44.
Cowan S, Lim S, Alycia C, et al. Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity. BMC Endocr Disord 2023; 23: 14.
45.
Armata I, Prakash A. An update on the assessment and management of hirsutism. Obstet Gynaecol Reprod Med 2024; 34: p81-7.
46.
Hendricks K, Nxumalo CT, Makgobole MU, et al. Evaluating the effectiveness of laser hair reduction using a home use laser in comparison to a diode laser. PLoS One 2023; 18: e0286162.
47.
Nistico SP, Bennardo L, Bennardo S, et al. Comparing traditional and in motion Nd:YAG laser in hair removal: a prospective study. Medicina (Kaunas) 2022; 58: 1205.
48.
Bhat YJ, Bashir S, Nabi N, et al. Laser treatment in hirsutism: an update. Dermatol Pract Concept 2020; 10: e2020048.
49.
Saad A, Mohammed J, Ziad M, et al. Hyperpigmentation post laser hair removal in patients taking vitamin D supplements. J Dermatol Dermatol Surg 2021; 25: 33-6.
50.
Hosseini MS, Ehsani AH, Fakour Y, et al. Effect of laser-assisted hair removal (LAHR) on the quality of life and depression in hirsute females: a single-arm clinical trial. J Lasers Med Sci 2022; 13: e46.
51.
Lee CM. Laser-assisted hair removal for facial hirsutism in women: a review of evidence. J Cosmet Laser Ther 2018; 20: 140-4.
52.
Bordewijk EM, Ng KYB, Rakic L, et al. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2020; 2: CD001122.
53.
Davies S. Hirsutism and quality of life. In: Handbook of Disease Burdens and Quality of Life Measures. Preedy VR, Watson RR (eds.). Springer, New York, NY 2010.
54.
Alur-Gupta S, Dokras A, Cooney LG. Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms. Fertil Steril 2024; 121: 384-99.
55.
Rajashekar S, Giri Ravindran S, Kakarla M, et al. Spironolactone versus oral contraceptive pills in the treatment of adolescent polycystic ovarian syndrome: a systematic review. Cureus 2022; 14: e25340.
56.
Fischer B, Gleason C, Asthana S. Effects of hormone therapy on cognition and mood. Fertil Steril 2014; 101: 898-904.
57.
Hodeeb YM, Dinary AM, Hassan MH, et al. Hirsutism and health related quality of life. Mod Chem Appl 2015; 3: 4.
58.
Prabakar AD. The power of thought: the role of psychological attentiveness and emotional support in patient trajectories. Yale J Biol Med 2024; 97: 3.